恶性黑素瘤的最新动态(六)
[6]Recchia F,Candeloro G,Necozone S,et al. Multicenter phase II study of chemoimmunotherapy in the treament of metastatic melanoma[J].Anticancer Drugs,2008,19(2):201-207.
[7]Atkins MB,Kunkel L,Sznol M, et al. High-dose recombinant interleukin-2 therapy in patients with metastaticmelanoma: long-term survival update[J].Cancer JSd Am,2000,6(suppl):S11-S14.
[8]Atkins MB.Interleukin-2 in metastatic melanoma: what is the current role[J]? Cancer JSd Am,2000,6(suppl):S8-S10.
[9]DiFronzo LA,Gupta RK,Essner R,et al.Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine[J].J Clin Oncol,2002,20:3242-3248.
[10]Deiner-West M,Earle JD,Fine SL,et al.Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled[J]. Arch Ophthalmol,2001,119:951-965.
[11]Ballo MT,Ang KK.Radiotherapy for cutaneous m alignant melanoma: rationale and indications[J].Oncology (Williston Park),2004,18:99-107.
[12]Ballo MT,Ross MI,Cormier JN,et al.Combined-modality therapy for patients with regional nodal metastases from melanoma[J].Int J Radiat Oncol Biol Phys,2006,64:106-113.
[收稿日期]2008-05-14
编辑/李阳利, 百拇医药(李荟元)
[7]Atkins MB,Kunkel L,Sznol M, et al. High-dose recombinant interleukin-2 therapy in patients with metastaticmelanoma: long-term survival update[J].Cancer JSd Am,2000,6(suppl):S11-S14.
[8]Atkins MB.Interleukin-2 in metastatic melanoma: what is the current role[J]? Cancer JSd Am,2000,6(suppl):S8-S10.
[9]DiFronzo LA,Gupta RK,Essner R,et al.Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine[J].J Clin Oncol,2002,20:3242-3248.
[10]Deiner-West M,Earle JD,Fine SL,et al.Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled[J]. Arch Ophthalmol,2001,119:951-965.
[11]Ballo MT,Ang KK.Radiotherapy for cutaneous m alignant melanoma: rationale and indications[J].Oncology (Williston Park),2004,18:99-107.
[12]Ballo MT,Ross MI,Cormier JN,et al.Combined-modality therapy for patients with regional nodal metastases from melanoma[J].Int J Radiat Oncol Biol Phys,2006,64:106-113.
[收稿日期]2008-05-14
编辑/李阳利, 百拇医药(李荟元)
参见：首页 > 医疗版 > 疾病专题 > 皮肤科 > 皮肤肿瘤 > 恶性黑素瘤